Literature DB >> 9264560

Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge--a personal perspective.

R C Boronow1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9264560     DOI： 10.1006/gyno.1997.4732

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  9 in total

1.  Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.

Authors:  Liuyan Jiang; Anais Malpica; Michael T Deavers; Ming Guo; Luisa Lina Villa; Gerard Nuovo; Maria J Merino; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2010-03       Impact factor: 2.762

2.  How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study.

Authors:  Sokbom Kang; Jong-Min Lee; Jae-Kwan Lee; Jae Weon Kim; Chi-Heum Cho; Seok-Mo Kim; Sang-Yoon Park; Chan-Yong Park; Ki-Tae Kim
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

3.  Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer.

Authors:  Sokbom Kang; Zachary Thompson; E Claire McClung; Reem Abdallah; Jae K Lee; Jesus Gonzalez-Bosquet; Robert M Wenham; Hye Sook Chon
Journal:  Int J Gynecol Cancer       Date:  2018-02       Impact factor: 3.437

4.  Major clinical research advances in gynecologic cancer in 2012.

Authors:  Dong Hoon Suh; Jae-Weon Kim; Kidong Kim; Hak Jae Kim; Kyung-Hun Lee
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

5.  Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.

Authors:  Bingyi Yang; Boer Shan; Xiaohong Xue; Huaying Wang; Weiwei Shan; Chengcheng Ning; Qiongjie Zhou; Xiaojun Chen; Xuezhen Luo
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

6.  Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer.

Authors:  Hyun Jin Choi; Sunyoung Lee; Byung Kwan Park; Tae Joong Kim; Chan Kyo Kim; Jung Jae Park; Chel Hun Choi; Yoo Young Lee; Jeong Won Lee; Duk Soo Bae; Byoung Gie Kim
Journal:  J Gynecol Oncol       Date:  2016-04-18       Impact factor: 4.401

7.  Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?

Authors:  Concetta Laliscia; Durim Delishaj; Maria Grazia Fabrini; Alessandra Gonnelli; Riccardo Morganti; Franco Perrone; Roberta Tana; Fabiola Paiar; Angiolo Gadducci
Journal:  J Contemp Brachytherapy       Date:  2016-12-09

8.  Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.

Authors:  Yu-Yang Hsiao; Hung-Chun Fu; Chen-Hsuan Wu; Jui Lan; Yu-Che Ou; Ching-Chou Tsai; Hao Lin
Journal:  Diagnostics (Basel)       Date:  2022-03-23

Review 9.  Endometrial carcinoma.

Authors:  W K Huh; J M Straughn; F J Kelly; L C Kilgore
Journal:  Curr Treat Options Oncol       Date:  2001-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.